Bacillus anthracis lethal toxin induces TNF-α-independent hypoxia-mediated toxicity in mice

Journal of Clinical Investigation

Volumn 112, Issue 5, 2003, Pages 670-682

  Moayeri, Mahtab ^a   Haines, Diana ^b   Young, Howard A ^c   Leppla, Stephen H ^a,d  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; CYTOKINE; EOTAXIN; FAS LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR; BACTERIAL ANTIGEN; BACTERIAL TOXIN; ENDOTHELIAL CELL GROWTH FACTOR; FASL PROTEIN, MOUSE; LYMPHOKINE; MEMBRANE PROTEIN; SIGNAL PEPTIDE; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACILLUS ANTHRACIS; BONE MARROW; CYTOKINE RELEASE; DISSEMINATED INTRAVASCULAR CLOTTING; HISTOPATHOLOGY; HYPOALBUMINEMIA; HYPOXIA; KIDNEY DYSFUNCTION; LIVER; LIVER DYSFUNCTION; LIVER NECROSIS; LUNG EDEMA; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SPLEEN; ANIMAL; ANOXIA; ANTHRAX; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; MACROPHAGE; METABOLISM; PATHOLOGY; PHYSIOLOGY; THYMUS;

ANIMALS; ANOXIA; ANTHRAX; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; BONE MARROW; CYTOKINES; ENDOTHELIAL GROWTH FACTORS; FAS LIGAND PROTEIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LYMPHOKINES; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SPLEEN; THYMUS GLAND; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 85047692288     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI17991     Document Type: Article

References (75)

1. Leppla, S.H. 1999. The bifactorial Bacillus anthracis lethal and oedema toxins. In Comprehensive sourcebook of bacterial protein toxins. J.E. Alouf and J.H. Freer, editors. Academic Press. London, United Kingdom. 243-263.
2. Beall, F.A., and Dalldorf, F.G. 1966. The pathogenesis of the lethal effect of anthrax toxin in the rat. J. Infect. Dis. 116:377-389.
3. Fish, D.C., Klein, F., Lincoln, R.E., Walker, J.S., and Dobbs, J.P. 1968. Pathophysiological changes in the rat associated with anthrax toxin. J. Infect. Dis. 118:114-124.
4. Klein, F., Hodges, D.R., Mahlandt, B.G., Jones, W.I., and Lincoln, R. 1962. Anthrax toxin: causative agent in the death of Rhesus monkeys. Science. 138:1331-1333.
5. Klein, F., et al. 1966. Pathophysiology of anthrax. J. Infect. Dis. 116:123-138.
6. Beall, F.A., Taylor, M.J., and Thorne, C.B. 1962. Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillus anthracis. J. Bacteriol. 83:1274-1280.
7. Smith, H., and Stoner, H.B. 1967. Anthrax toxic complex. Fed. Proc. 26:1554-1557.
8. Ezzell, J.W., Ivins, B.E., and Leppla, S.H. 1984. Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin. Infect. Immun. 45:761-767.
9. Abramova, F.A., Grinberg, L.M., Yampolskaya, O.V., and Walker, D.H. 1993. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc. Natl. Acad. Sci. U. S. A. 90:2291-2294.
10. Borio, L., et al. 2001. Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA. 286:2554-2559.
11. Jernigan, J.A., et al. 2001. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis. 7:933-944.
12. Mayer, T.A., et al. 2001. Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. JAMA. 286:2549-2553.
13. Earls, J.P., et al. 2002. Inhalational anthrax after bioterrorism exposure: spectrum of imaging findings in two surviving patients. Radiology. 222:305-312.
14. Brachman, P.S. 1980. Inhalation anthrax. Ann. N. Y. Acad. Sci. 353:83-93.
15. Pezard, C., Duflot, E., and Mock, M. 1993. Construction of Bacillus anthracis mutant strains producing a single toxin component. J. Gen. Microbiol. 139:2459-2463.
16. Pezard, C., Berche, P., and Mock, M. 1991. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 59:3472-3477.
17. Welkos, S.L., Keener, T.J., and Gibbs, P.H. 1986. Differences in susceptibility of inbred mice to Bacillus anthracis. Infect. Immun. 51:795-800.
18. Hanna, P.C., Acosta, D., and Collier, R.J. 1993. On the role of macrophages in anthrax. Proc. Natl. Acad. Sci. U. S. A. 90:10198-10201.
19. Erwin, J.L., et al. 2001. Macrophage-derived cell lines do not express proinflammatory cycokines after exposure to Bacillus anthracis lethal toxin. Inject. Immun. 69:1175-1177.
20. Pellizzari, R., Guidi-Rontani, C., Vitale, G., Mock, M., and Montecucco, C. 1999. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett. 462:199-204.
21. Pellizzari, R., Guidi-Rontani, C., Vitale, G., Mock, M., and Montecucco, C. 2000. Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs: analysis of the intracellular consequences in macrophages. Int. J. Med. Microbiol. 290:421-427.
22. Duesbery, N.S., et al. 1998. Proteolycic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science. 280:734-737.
23. Vitale, G., et al. 1998. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248:706-711.
24. Vitale, G., Bernardi, L., Napolitani, G., Mock, M., and Montecucco, C. 2000. Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem. J. 352:739-745.
25. Kalns, J., et al. 2002. TNF receptor 1, IL-1 receptor, and iNOS genetic knockout mice are not protected from anthrax infection. Biochem. Biophys. Res. Commun. 292:41-44.
26. Bunner, D.L., Morris, E.R., and Mereish, K.A. 1993. Effects of anthrax toxin (protective antigen and lethal factor) on human monocytes and polymorphonuclear leukocytes. In Vitro Toxicology. 6:81-89.
27. Varughese, M., et al. 1998. Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies. Mol. Med. 4:87-95.
28. Klimpel, K.K., Arora, N., and Leppla, S.H. 1994. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol. Microbiol. 13:1093-1100.
29. Hoover, S.B., Sung, C., Cottler-Fox, M.H., and Fox, C.H. 2000. In situ hybridization techniques for studying gene expression in the genetically altered mouse. In Pathology of genetically engineered mice. J.M. Ward, J.F. Mahler, R.R. Maronpot, and J.P. Sundberg, editors. Iowa State University Press. Ames, Iowa, USA. 13-22.
30. Roberts, J.E., Watters, J.W., Ballard, J.D., and Dietrich, W.F. 1998. Ltx1, a mouse locus that influences the susceptibility of macrophages to cytolysis caused by intoxication with Bacillus anthracts lethal factor, maps to chromosome 11. Mol. Microbiol. 29:581-591.
31. Lacombe, C., and Mayeux, P. 1998. Biology of erythropoietin. Haematologica. 83:724-732.
32. Hoetzel, A., et al. 2001. Effect of nitric oxide on shock-induced hepatic heme oxygenase-1 expression in the rat. Hepatology. 33:925-937.
33. Benjamin, I.J., Kroger, B., and Williams, R.S. 1990. Activation of the heat shock transcription factor by hypoxia in mammalian cells. Proc. Natl. Acad Sci. U. S. A. 87:6263-6267.
34. Lee, P.J., et al. 1997. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272:5375-5381.
35. Kaner, R.J., et al. 2000. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am. J. Respir. Cell Mol. Biol. 22:657-664.
36. Grove, C.S., and Lee, Y.C. 2002. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr. Opin. Pulm. Med. 8:294-301.
37. Bates, D.O., Hillman, N.J., Williams, B., Neal, C.R., and Pocock, T.M. 2002. Regulation of microvascular permeability by vascular endothelial growth factors. J. Anat. 200:581-597.
38. Forsythe, J.A., et al. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16:4604-4613.
39. Pinkoski, M.J., Brunner, T., Green, D.R., and Lin, T. 2000. Fas and Fas ligand in gut and liver. Am. J. Physiol. Gastrointest. Liver Physiol. 278:G354-G366.
40. Kayagaki, N., et al. 1997. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. U. S. A. 94: 3914-3919.
41. Hanna, P.C., Kruskal, B.A., Ezekowitz, R.A., Bloom, B.R., and Collier, R.J. 1994. Role of macrophage oxidative burst in the action of anthrax lethal toxin. Mol. Med. 1:7-18.
42. Kalns, J., Morris, J., Eggers, J., and Kiel, J. 2002. Delayed treatment with doxycycline has limited effect on anthrax infection in BLK57/B6 mice. Biochem. Biophys. Res. Commun. 297:506-509.
43. Mahalingam, S., and Karupiah, G. 1999. Chemokines and chemokine receptors in infectious diseases. Immunol. Cell Biol. 77:469-475.
44. Calkins, C.M., et al. 2002. IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia. J. Endotoxin Res. 8:59-67.
45. Sica, A., et al. 1990. IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology. 69:548-553.
46. Sironi, M., et al. 1989. IL-1 stimulates IL-6 production in endothelial cells. J. Immunol. 142:549-553.
47. Mantovani, A., Locati, M., Allavena, P., and Sozzani, S. 1996. The chemokine superfamily: crosstalk with the IL-1 system. Immunobiology. 195:522-549.
48. Beezhold, D.H., Best, G.K., Bonventre, P.F., and Thompson, M. 1989. Endotoxin enhancement of toxic shock syndrome toxin 1-induced secretion of interleukin 1 by murine macrophages. Rev. Infect. Dis. 11(Suppl. 1):S289-S293.
49. Kovacs, E.J., Radzioch, D., Young, H.A., and Varesio, L. 1988. Differential inhibition of IL-1 and TNF-alpha mRNA expression by agents which block second messenger pathways in murine macrophages. J. Immunol. 141:3101-3105.
50. Heinzel, F.P., Sadick, M.D., Mutha, S.S., and Locksley, R.M. 1991. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. U. S. A. 88:7011-7015.
51. Szeliga, J., Fiuk, D., Walencka, M., and Goscicka, T. 1997. Interleukin 12 and direct cytotoxicity of spleen lymphocytes to Listeria innocua-phagocyting syngeneic macrophages in C57BL/6 and BALB/c mice. Arch. Immunol. Ther. Exp. (Warsz). 45:49-54.
52. Autenrieth, I.B., Beer, M., Bohn, E., Kaufmann, S.H., and Heesemann, J. 1994. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect. Immun. 62:2590-2599.
53. Stenger, S., Thuring, H., Rollinghoff, M., and Bogdan, C. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783-793.
54. Kaushik, R.S., Uzonna, J.E., Gordon, J.R., and Tabel, H. 1999. Innate resistance to Trypanosoma congolense infections: differential production of nitric oxide by macrophages from susceptible BALB/c and resistant C57B1/6 mice. Exp. Parasitol. 92:131-143.
55. Shanks, N., Griffiths, J., and Anisman, H. 1994. Norepinephrine and serotonin alterations following chronic stressor exposure: mouse strain differences. Pharmacol. Biochem. Behav. 49:57-65.
56. Shanks, N., Griffiths, J., Zalcman, S., Zacharko, R.M., and Anisman, H. 1990. Mouse strain differences in plasma corticosterone following uncontrollable footshock. Pharmacol. Biochem. Behav. 36:515-519.
57. Price, P., et al. 1996. Adrenalitis and the adrenocortical response of resistant and susceptible mice to acute murine cytomegalovirus infection. Eur. J. Clin. Invest. 26:811-819.
58. Bogdanov, N.N., and Soldarov, P.E. 1999. C57B1/6 mice are more resistant to hypoxic hypoxia than BALB/c mice. Biull. Eksp. Biol. Med. 128:511-513.
59. Meerson, F.S., and Maizelis, M.I. 1973. Influence of adaptation hypoxia on the brain function and its resistance to noxious factors. Zh. Neuropatol. Psikhbiatr. Im. S. S. Korsakova. 73:1414-1421.
60. Grinberg, L.M., Abramova, F.A., Yampolskaya, O.V., Walker, D.H., and Smith, J.H. 2001. Quantitative pathology of inhalational anthrax I: quantitative microscopic findings. Mod. Pathol. 14:482-495.
61. Rangel, R.A., and Gonzalez, D.A. 1975. Bacillus anthracis meningitis. Neurology. 25:525-530.
62. Pluot, M., et al. 1976. Anthrax meningitis. Report of two cases with autopsies. Acta Neuropathol. (Berl.). 36:339-345.
63. Dalldorf, F.G., and Beall, F.A. 1967. Capillary thrombosis as a cause of death in experimental anthrax. Arch. Pathol. 83:154-161.
64. Zaucha, G.M., Pitt, M.L., Esrep, J., Ivins, B.E., and Friedlander, A.M. 1998. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch. Pathol. Lab. Med. 122:982-992.
65. Plotkin, S.A., Brachman, P.S., Utell, M., Bumford, F.H., and Atchison, M.M. 2002. An epidemic of inhalation anthrax, the first in the twentieth century. I. Clinical features. 1960. Am. J. Med. 112:4-12.
66. Gleiser, C.A. 1967. Pathology of anthrax infection in animal hosts. Fed. Proc. 26:1518-1521.
67. Aster, R.H. 1999. Drug-induced immune thrombocytopenia: an overview of pathogenesis. Semin. Hematol. 36:2-6.
68. Burgess, J.K. 2001. Molecular mechanisms of drug-induced thrombocytopenia. Curr. Opin. Hematol. 8:294-298.
69. Fernandez, G.E. 2001. Hantavirus. Prim. Care Update Ob Gyns. 8:53-58.
70. Kanerva, M., Mustonen, J., and Vaheri, A. 1998. Pathogenesis of puumala and other hantavirus infections. Rev. Med. Virol. 8:67-86.
71. Dutz, W., Saidi, F., and Kohout, E. 1970. Gastric anthrax with massive ascites. Gut. 11:352-354.
72. Sirisanthana, T., Navachareon, N., Tharavichitkul, P., Sirisanthana, V., and Brown, A.E. 1984. Outbreak of oral-oropharyngeal anthrax: an unusual manifestation of human infection with Bacillus anthracis. Am. J. Trop. Med. Hyg. 33:144-150.
73. Wade, B.H., Wright, G.G., Hewlett, E.L., Leppla, S.H., and Mandell, G.L. 1985. Anthrax toxin components stimulate chemotaxis of human polymorphonuclear neutrophils. Proc. Soc. Exp. Biol. Med. 179:159-162.
74. Kau, J., et al. 2001. Platelet, the novel action target of anthrax. In 4th International Conference on Anthrax: Programs and Abstracts. Annapolis, Maryland, USA.
75. Lucchesi, B.R. 1994. Complement, neutrophils and free radicals: mediators of reperfusion injury. Arzneimittelforschung, 44:420-432.